D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
GE Vernova
GEV
|
+$601M |
| 2 |
Walt Disney
DIS
|
+$510M |
| 3 |
Palantir
PLTR
|
+$502M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$490M |
| 5 |
TSMC
TSM
|
+$396M |
Top Sells
| 1 |
Boeing
BA
|
+$967M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$567M |
| 4 |
Eli Lilly
LLY
|
+$551M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| 1 | Technology | 20.32% |
| 2 | Healthcare | 13% |
| 3 | Consumer Discretionary | 12.32% |
| 4 | Financials | 8.62% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Vir Biotechnology
VIR
$695M
| $3.28M | ﹤0.01% |
506,704
+4,704
| +0.9% | +$30.5K |
|
1452
Alignment Healthcare
ALHC
$3.18B
| $3.28M | ﹤0.01% |
176,239
-8,375
| -5% | -$156K |
|
1453
Couchbase
BASE
$1.35B
| $3.28M | ﹤0.01% |
208,038
+38,920
| +23% | +$613K |
|
1454
Clearfield
CLFD
$453M
| $3.28M | ﹤0.01% |
110,241
+51,781
| +89% | +$1.54M |
|
1455
Pulmonx
LUNG
$69.3M
| $3.27M | ﹤0.01% |
486,555
+93,719
| +24% | +$631K |
|
1456
Select Medical
SEM
$1.55B
| $3.27M | ﹤0.01% |
196,024
+146,694
| +297% | +$2.45M |
|
1457
CompoSecure, Inc. Warrant
CMPOW
$1.17B
| $3.27M | ﹤0.01% |
843,130
+3,600
| +0.4% | +$14K |
|
1458
Ouster
OUST
$1.67B
| $3.27M | ﹤0.01% |
363,726
-900,717
| -71% | -$8.09M |
|
1459
United Fire Group
UFCS
$807M
| $3.27M | ﹤0.01% |
110,856
+25,217
| +29% | +$743K |
|
|
GAP
1460
The Gap, Inc.
GAP
$8.5B
| $3.26M | ﹤0.01% |
158,204
+79,379
| +101% | +$1.64M |
|
|
PGAC
1461
Pantages Capital Acquisition Corporation Class A Ordinary Shares
PGAC
$113M
| $3.26M | ﹤0.01% |
+325,000
| New | +$3.26M |
|
1462
HNI Corp
HNI
$2.07B
| $3.25M | ﹤0.01% |
+73,313
| New | +$3.25M |
|
1463
American Water Works
AWK
$27.2B
| $3.24M | ﹤0.01% |
+21,983
| New | +$3.24M |
|
1464
Nutrien
NTR
$27.7B
| $3.24M | ﹤0.01% |
65,265
-305,448
| -82% | -$15.2M |
|
1465
BrightView Holdings
BV
$1.32B
| $3.24M | ﹤0.01% |
252,301
+7,964
| +3% | +$102K |
|
|
TBCH
1466
Turtle Beach Corporation Common Stock
TBCH
$299M
| $3.23M | ﹤0.01% |
226,521
-76,656
| -25% | -$1.09M |
|
1467
iShares MSCI Australia ETF
EWA
$1.55B
| $3.22M | ﹤0.01% |
137,321
+97,268
| +243% | +$2.28M |
|
1468
Compass Diversified
CODI
$527M
| $3.22M | ﹤0.01% |
172,343
+122,964
| +249% | +$2.3M |
|
1469
Accuray
ARAY
$177M
| $3.21M | ﹤0.01% |
1,793,391
| – | – |
|
|
DX
1470
Dynex Capital
DX
$1.63B
| $3.21M | ﹤0.01% |
+246,546
| New | +$3.21M |
|
1471
Synaptics
SYNA
$2.72B
| $3.21M | ﹤0.01% |
50,315
-146,429
| -74% | -$9.33M |
|
1472
Gold Fields
GFI
$33.7B
| $3.2M | ﹤0.01% |
+145,016
| New | +$3.2M |
|
1473
Ascendis Pharma
ASND
$11.8B
| $3.2M | ﹤0.01% |
20,526
-17,454
| -46% | -$2.72M |
|
1474
Eastman Chemical
EMN
$7.71B
| $3.2M | ﹤0.01% |
+36,284
| New | +$3.2M |
|
1475
ArcBest
ARCB
$1.6B
| $3.2M | ﹤0.01% |
+45,295
| New | +$3.2M |
|